RhumbLine Advisers
IMGO

RhumbLine Advisers’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

RhumbLine Advisers’s Portfolio IMGO Stock Details IMGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-37,134
Closed -$1.33M – 3003
2022
Q4 		$1.33M Buy
37,134
+2,101
+6% +$52.5K ﹤0.01% 1998
2022
Q3 		$527K Buy
35,033
+2,278
+7% +$37K ﹤0.01% 2473
2022
Q2 		$439K Buy
32,755
+14,874
+83% +$236K ﹤0.01% 2567
2022
Q1 		$345K Buy
+17,881
New +$371K ﹤0.01% 2595

RhumbLine Advisers's IMGO Position: Q1 2023 in Review

RhumbLine Advisers sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 37,134 shares — an estimated $1.33M sold.

RhumbLine Advisers first reported a position in IMGO in Q1 2022 and held it in 4 quarters. The position peaked at $1.33M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • RhumbLine Advisers reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
  • RhumbLine Advisers sold 37,134 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $1.33M.
  • RhumbLine Advisers first reported a position in Imago BioSciences, Inc. Common stock in Q1 2022 and held it in 4 quarters.
  • RhumbLine Advisers's Imago BioSciences, Inc. Common stock position peaked at $1.33M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.